263 related articles for article (PubMed ID: 8604492)
1. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity.
Fain J; Hilsenrath P; Widness JA; Strauss RG; Mutnick AH
Transfusion; 1995; 35(11):936-43. PubMed ID: 8604492
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.
Shireman TI; Hilsenrath PE; Strauss RG; Widness JA; Mutnick AH
Arch Pediatr Adolesc Med; 1994 Jun; 148(6):582-8. PubMed ID: 8193681
[TBL] [Abstract][Full Text] [Related]
3. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
4. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
6. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
8. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
[TBL] [Abstract][Full Text] [Related]
9. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.
Strauss RG
Transfus Med Rev; 2001 Jul; 15(3):213-23. PubMed ID: 11471123
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin as a treatment for anemia of prematurity.
Downey P
J Perinat Neonatal Nurs; 1997 Dec; 11(3):57-68. PubMed ID: 9451192
[TBL] [Abstract][Full Text] [Related]
11. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
Dallman PR
Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
[No Abstract] [Full Text] [Related]
12. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony-stimulating factor for treatment of the anemia of prematurity.
Christensen RD; Hunter DD; Ohls RK
J Perinatol; 1994; 14(2):110-3. PubMed ID: 8014692
[TBL] [Abstract][Full Text] [Related]
13. Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
Phibbs RH
Curr Opin Pediatr; 1995 Apr; 7(2):140-5. PubMed ID: 7787927
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors: Part II.
Wandstrat TL; Wolfe M
Neonatal Netw; 1996 Oct; 15(7):25-8. PubMed ID: 9035641
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant erythropoietin in treatment of the anemia of prematurity.
Halpérin DS
Am J Pediatr Hematol Oncol; 1991; 13(3):351-63. PubMed ID: 1793163
[TBL] [Abstract][Full Text] [Related]
16. [Decreased transfusions in preterm infants with anemia treated with erythropoietin].
López-Catzín JF; Bolado-García PB; Gamboa-López GJ; Medina-Escobedo CE; Cambranes-Catzima LR
Rev Med Inst Mex Seguro Soc; 2016; 54(5):576-80. PubMed ID: 27428338
[TBL] [Abstract][Full Text] [Related]
17. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
Ohls RK; Christensen RD
J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.
MacLaren R; Sullivan PW
Value Health; 2005; 8(2):105-16. PubMed ID: 15804319
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trial.
Kamholz KL; Dukhovny D; Kirpalani H; Whyte RK; Roberts RS; Wang N; Mao W; Zupancic JA;
Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F93-8. PubMed ID: 21733926
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
